Skip to main content
. 2021 Jul 6;25(11):1231–1239. doi: 10.1007/s10157-021-02100-0

Table 5.

Number of patients by starting dose and CKD stage (N = 1618)

Starting dose
CKD stage  < 60 mg 60 mg

 G1

 G2

 G3a

 G3b

 G4

Total

12 (0.7%)

79 (4.9%)

95 (5.9%)

153 (9.5%)

286 (17.7%)

625 (38.6%)

50 (3.1%)

220 (13.6%)

232 (14.3%)

287 (17.7%)

204 (12.6%)

993 (61.4%)

Categorical variables are expressed as n (%)